Section one: Contracting authority
one.1) Name and addresses
Portsmouth City Council
Civic Offices, Guildhall Square
Portsmouth
PO12AL
procurement@portsmouthcc.gov.uk
Country
United Kingdom
Region code
UKJ31 - Portsmouth
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
https://www.portsmouth.gov.uk/
one.4) Type of the contracting authority
Regional or local authority
one.5) Main activity
General public services
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Portsmouth City Council Staff Flu Vaccination Programme
two.1.2) Main CPV code
- 85149000 - Pharmacy services
two.1.3) Type of contract
Services
two.1.4) Short description
Portsmouth City Council intends to award a contract to an existing provider for the provision of an existing service, the staff flu vaccination programme.
The aim of the service is to increase the provision of and access to seasonal influenza immunisation for eligible employees of Portsmouth City Council, especially among those working with vulnerable/at risk clients. It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500.
The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023, following Direct Award Process C. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £12,500
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKJ31 - Portsmouth
two.2.4) Description of the procurement
Portsmouth City Council intends to award a contract to an existing provider for the provision of an existing service, the staff flu vaccination programme, following Direct Award Process C under the Provider Selection Regime (PSR) Regulations 2023.
This Service will increase the provision of and access to seasonal influenza immunisation for eligible employees of Portsmouth City Council (including Councillors and Port staff), HIOW ICB and Gosport Borough Council. In particular, the quadrivalent seasonal influenza vaccine that the Joint Committee on Vaccinations and Immunisations (JCVI) recommend is issued to frontline health and social care workers.
The provision of this service is expected to facilitate flu vaccine uptake, especially among those working with vulnerable/at risk clients. This is to reduce the serious morbidity and mortality of influenza by immunising those who care for individuals who are more likely to have a serious or complicated illness should they develop influenza.
It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: Yes
Description of options
It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 nor the Procurement Act 2023 do not apply to this award.
The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 13th October. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
1 October 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
J C L (U.K.) LTD.
Portsmouth
Country
United Kingdom
NUTS code
- UKJ31 - Portsmouth
Companies House
03212838
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £12,500
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by midnight on 13th October 2025 via email to phcontracts@portsmouthcc.gov.uk. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
The decisions makers are commissioners of the Public Health directorate at Portsmouth City Council. There were no conflicts of interest identified.
Through the assessment of the existing provider in accordance with each of the Key Criteria listed under the PSR Regulations 2023, Direct Award Process C, it was identified that the existing provider satisfies the original contract with no concerns identified. They will likely be able to satisfy the new contract to a sufficient standard.
The key criteria were taken in consideration as follows: Quality and innovation (20%), Value (20%), Integration, Collaboration and Service Sustainability (15%), Improving access, reducing health inequalities and facilitating choice (30%), Social Value (15%)
six.4) Procedures for review
six.4.1) Review body
Independent Patient Choice and Procurement Panel
London
Country
United Kingdom